Pay in 4 interest-free payments of $6.51 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
FGF19 can interact with both Klotho co-receptor proteins
Senate Committee on Health, Education, Labor & Pensions. Senate.gov, Senate Committee on Health, Education, Labor and Pensions, 24 Sept
***Based on a 6-month clinical trial (n=180) of individuals who were enrolled between FebruaryApril 2024, with overweight or obesity taking semaglutide or tirzepatide for weight loss and related outcomes through the WW Clinic Program and participating in the GLP-1 companion nutrition program
General Eligibility BMI of 30 or higher (classified as obesity) BMI of 27 or higher with a weight-related health condition such as type 2 diabetes, high blood pressure, high cholesterol, or sleep apnea No contraindications specific to the medication being considered Willingness to commit to regular monitoring appointments Finding the Right Medication Not everyone needs the highest-efficacy medication
Kirstie Canene-Adams, Director, Nutrition Center, shares that due to the possible muscle loss while on anti-obesity medications, protein intake is really important
US$ 26.63
US$ 24.03
US$ 24.77
US$ 26.66
US$ 22.41
US$ 26.12
US$ 23.98
US$ 26.38
US$ 27.24
